Urothelial Carcinoma Stem Cells: Current Concepts, Controversies, and Methods

Area of Science:

• Oncology
• Stem Cell Biology
• Urothelial Carcinoma Research

Background:

• Cancer stem cells (CSCs) are a critical subpopulation driving tumor growth and recurrence.
• Urothelial carcinoma (UC) research is exploring CSCs for better treatment strategies.
• Understanding CSC heterogeneity is key to overcoming therapeutic resistance.

Purpose of the Study:

• To review and discuss methods for purifying cancer stem cells in urothelial carcinoma.
• To highlight the heterogeneity of CSCs in bladder cancer.
• To identify potential translational applications of CSC research in UC.

Main Methods:

• Marker-based approaches utilizing cell surface markers (e.g., CD14, CD44, CD90, 67LR).
• Marker-free approaches including side population sorting and Aldefluor assay (aldehyde dehydrogenase activity).
• Application of these assays to non-muscle-invasive and muscle-invasive bladder cancer samples and cell lines.

Main Results:

• Both marker-based and marker-free methods are applicable for CSC purification in UC.
• UC CSCs exhibit significant molecular heterogeneity in their stemness mechanisms.
• A CD44+ gene expression signature shows potential for predicting progression in non-muscle-invasive bladder cancer.

Conclusions:

• Cancer stem cell identification and characterization are crucial for advancing urothelial carcinoma treatment.
• Further research into CSC mechanisms, particularly therapeutic resistance, is warranted.
• Translational development of CSC-targeting strategies holds promise for improving patient outcomes.